Wang X et al., 2025-08-13: Randomized trial comparing platelet-rich plasma with methylene blue injection in discogenic low back pain, in which PRP outperformed methylene blue on pain and function at six months.
Compared with a methylene blue injection, platelet-rich plasma can significantly reduce pain, improve the function of the lumbar spine, increase the diffusion ability of water molecules in the intervertebral disc, and improve the degree of intervertebral discogenic degeneration in patients with discogenic low back pain.
Wang X et al., 2025-08-13: Randomized trial comparing platelet-rich plasma with methylene blue injection in discogenic low back pain, in which PRP outperformed methylene blue on pain and function at six months. Study type: prospective randomized controlled trial. N=40 (20 PRP, 20 MB). Country: China. Intradiscal methylene blue versus intradiscal PRP; doses not in abstract; 6-month follow-up. Funding/conflicts: none declared. Comparator: active comparator (PRP). Bearing CONTRADICTS the claim that MB is the effective injection: the comparator beat it. Study type: randomized trial.
